Evidence map›Paper›PMID 41504703›Full record

ArticleBJS open2025

Comparative effectiveness of preoperative localization techniques for non-palpable breast lesions: multicentre real-world study.

Fabio Corsi, Sara Albasini, Matilde Pelizzola, Carlo Morasso, Giulia Armatura, Alessandro Asaro, Corrado Chiappa, Virginia Coli, Francesca Combi, Angelica Della Valle and 17 more

Abstract readMulticenter StudyComparative Study
In one paragraph

Article in BJS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Fabio CorsiDepartment of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Sara AlbasiniBreast Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.ORCID 0000-0002-8764-3919
Matilde PelizzolaGeneral Surgery Residency Program, University of Milan, Milan, Italy.
Carlo MorassoBreast Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.ORCID 0000-0001-9185-0198
Giulia ArmaturaChirurgia Plastica e Senologica, Azienda Provinciale per i Servizi Sanitari di Trento, Trento, Italy.
Alessandro AsaroBreast Surgery Unit, Department of Surgery, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milano, Italy.
Corrado ChiappaSC Breast Unit, ASST-Settelaghi di Varese, Varese, Italy.
Virginia ColiUOSD Oncologia Chirurgica Ricostruttiva della Mammella, PO 'F.Lotti'-USL Toscana Nordovest, Pontedera, Italy.
Francesca CombiDivision of Breast Surgical Oncology, Department of Medical and Surgical, Maternal-Infantile and Adult Sciences, University Hospital of Modena, Modena, Italy.
Angelica Della ValleGeneral Surgery 3- Breast Surgery, Department of Surgery, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Raimondo Di GiacomoDivisione di Chirurgia Oncologica Senologica, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Secondo FolliBreast Unit, Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Maria Luisa GasparriDepartment of Gynecology and Obstetrics, Ente Ospedaliero Cantonale (EOC), Ospedale Regionale di Lugano, Lugano, Switzerland.ORCID 0000-0002-9482-9527
Massimo Maria GrassiBreast Unit, Humanitas Gavazzeni e Castelli, Bergamo, Italy.
Stefano ManciniBreast Surgery Unit, Department of Surgery, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milano, Italy.
Ilaria MaugeriBreast Unit, Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Marica MelinaBreast Unit, IRCCS Azienda Ospedaliero-Universitaria, Bologna, Italy.
Andrea PapadiaDepartment of Gynecology and Obstetrics, Ente Ospedaliero Cantonale (EOC), Ospedale Regionale di Lugano, Lugano, Switzerland.
Lorenzo RossiCentro di Senologia della Svizzera Italiana (CSSI), Ospedale Italiano di Lugano, Lugano, Switzerland.
Laura RovedaUOSD Oncologia Chirurgica Ricostruttiva della Mammella, PO 'F.Lotti'-USL Toscana Nordovest, Pontedera, Italy.
Francesca RoveraSC Breast Unit, ASST-Settelaghi di Varese, Varese, Italy.
Silvia SegattiniDivision of Breast Surgical Oncology, Department of Medical and Surgical, Maternal-Infantile and Adult Sciences, University Hospital of Modena, Modena, Italy.
Adele SgarellaGeneral Surgery 3- Breast Surgery, Department of Surgery, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Claudio SianiDivisione di Chirurgia Oncologica Senologica, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Norma StefenelliChirurgia Plastica e Senologica, Azienda Provinciale per i Servizi Sanitari di Trento, Trento, Italy.
Francesco ValentiBreast Unit, Humanitas Gavazzeni e Castelli, Bergamo, Italy.
Simone ZanottiBreast Unit, IRCCS Azienda Ospedaliero-Universitaria, Bologna, Italy.

Funding

European Innovation CouncilHorizon Europe programme 101187508Italian Ministry of Health
6 · The paper itself

Abstract

backgroundThe increasing detection of non-palpable breast lesions has made accurate preoperative localization essential to optimize breast-conserving surgery. Although multiple localization methods exist, there is still a lack of robust, large-scale, multicentre evaluations comparing different techniques.

methodsThe LOCALIZATION01 study compares real-world data from 13 breast units in Italy and Switzerland on the impact of localization techniques on breast-conserving surgery for non-palpable lesions between 2016 and 2024. Four localization techniques were compared: wire-guided (WGL), radio-guided (ROLL), magnetic seed (MSL), and carbon (CL). The main outcomes were margin status, calculated resection ratio, postoperative complications, and surgical time. Subgroup analyses were performed for body mass index, lesion morphology and histopathology.

resultsIn total, 3241 patients were enrolled (ROLL 985, MSL 592, WGL 1079, and CL 585). ROLL achieved the highest rate of negative surgical margins, significantly outperforming MSL, WGL, and CL (97.5% versus 94.7% versus 94.5% versus 90.6%, respectively; P < 0.05). CL was associated with the highest postoperative complications rate (16.7%) versus ROLL (4.1%), MSL (4.5%), and WGL (2.1%) (P < 0.0001). The surgical time for MSL was significantly shorter when compared with WGL (46 versus 70 minutes (min); P < 0.0001) and CL (55 min; P < 0.0001). WGL had the most favourable calculated resection ratio (2.4), followed by MSL (2.6), ROLL (2.7), and CL (3.0). Multivariable analysis identified CL as an independent predictor of positive margins (odds ratio 1.82; P = 0.004), whereas ROLL was protective (odds ratio 0.45; P = 0.009).

conclusionROLL and MSL outperformed WGL and CL across multiple endpoints. CL data revealed objective limitations that suggest caution in its use. A personalized approach considering lesion morphology, body mass index, and logistics is recommended.

Indexed as

Breast NeoplasmsMastectomy, SegmentalPreoperative CareAdultAgedBreastFemaleHumansItalyMargins of ExcisionMiddle AgedOperative TimePostoperative ComplicationsRetrospective StudiesSwitzerlandbreast-conserving surgerycarbon localizationmagnetic seed localizationradio-guided occult lesion localizationsurgical marginswire-guided localization

Identifiers

PMID41504703
PMCPMC12781200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.